CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Deferiprone

Last Updated: August 26, 2015
Result type: Reports
Project Number: SR0448-000
Product Line: Reimbursement Review

Generic Name: Deferiprone

Brand Name: Ferriprox

Manufacturer: ApoPharma Inc.

Therapeutic Area: Transfusional iron overload

Indications: Transfusional iron overload

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 18, 2016

Recommendation Type: List with clinical criteria and/or conditions